Type 2 diabetes is not only an independent risk factor for cardiovascular (CV) disease but is also associated with a greater incidence of heart failure (HF). The aim of this review is to examine the effects of oral antidiabetic drugs on CV disease and HF.
Kappel, B., Marx, N., Federici, M. (2015). Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 25(8), 697-705 [10.1016/j.numecd.2015.06.006].
Oral hypoglycemic agents and the heart failure conundrum: Lessons from and for outcome trials
FEDERICI, MASSIMO
2015-01-01
Abstract
Type 2 diabetes is not only an independent risk factor for cardiovascular (CV) disease but is also associated with a greater incidence of heart failure (HF). The aim of this review is to examine the effects of oral antidiabetic drugs on CV disease and HF.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
